Clinical Edge Journal Scan

Breast cancer and thyroid cancer: What is the link?


 

Key clinical point: Higher genetic susceptibility to breast cancer (BC) is associated with an increased risk for overall thyroid cancer; however, this association is not valid in case of triple-negative BC (TNBC) and thyroid cancer.

Major finding: The risk for thyroid cancer was significantly elevated in patients with BC (odds ratio 1.135; P = .038); however, no causal link was observed between TNBC and thyroid cancer (OR 0.817; P = .177).

Study details: Findings are from a two-sample mendelian randomization analysis including 133,384 patients with BC and 113,789 BC-free control individuals.

Disclosures: This study was supported by funding from the National Natural Science Foundation of China and other sources. The authors declared no conflicts of interest.

Source: Tan H et al. Association between breast cancer and thyroid cancer risk: A two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1138149 (May 23). doi: 10.3389/fendo.2023.1138149

Recommended Reading

HR+/ERBB2+ early BC: Excellent pCR rate with de-escalated neoadjuvant paclitaxel plus trastuzumab and pertuzumab
MDedge Hematology and Oncology
Simultaneous integrated boost noninferior to sequential boost in phase 3 in early BC
MDedge Hematology and Oncology
18F-labeled fluorodeoxyglucose PET-CT detects more distant metastases than conventional staging in locally advanced BC
MDedge Hematology and Oncology
Presence of breast cancer or other cancers in first-degree relatives increases risk for ER-subtypes of BC
MDedge Hematology and Oncology
Surgery may improve outcomes in de novo HER2+ metastatic inflammatory BC
MDedge Hematology and Oncology
Adjuvant capecitabine is remarkably well tolerated in the real world in patients with TNBC
MDedge Hematology and Oncology
Meta-analysis demonstrates association between aspirin intake and reduced BC risk
MDedge Hematology and Oncology
Atypical hyperplasia at surgical margins need not be re-excised in BC patients undergoing BCS and NAC
MDedge Hematology and Oncology
Oral apatinib-etoposide combo may be administered in pretreated advanced TNBC
MDedge Hematology and Oncology
Family history of breast cancer in first-degree relatives may increase risk for certain cancers in men
MDedge Hematology and Oncology